Advertisement

Topics

Latest "Helix Opco" News Stories

00:56 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Helix Opco" found in our extensive news archives from over 250 global news sources.

More Information about Helix Opco on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Helix Opco for you to read. Along with our medical data and news we also list Helix Opco Clinical Trials, which are updated daily. BioPortfolio also has a large database of Helix Opco Companies for you to search.

Showing "Helix Opco" News Articles 1–25 of 83

Relevant

Promega UK Announces Winners of the First Helix Sustainability Awards

Promega UK, the Life Sciences Company, based on the University of Southampton Science Park in Hampshire, has announced the winners of its first Helix Sustainability award. Helix is an onsite RFID (Radio Frequency Identification) laboratory storage system used to support scientists with their life sciences research fighting diseases such as Cancer and Alzheimer’s....


ON Helix: Start-Up Café

ON Helix run by One Nucleus will be held on the 13th July. This year they’re introducing a new opportunity for start-ups to showcase themselves.

The helix, of DNA fame, may have arisen with startling ease

(Georgia Institute of Technology) Here's a science enigma: Try to explain where the neat, even DNA/RNA helix came from. Ha! Easy one! It probably spun around itself long before first life evolved like it did in a lab. In fact, the twist could have helped select the components of RNA, not the other way around.


Helix Homes America Asia Expansion

SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- Helix Homes America announces the two-year anniversary of Indonesia operations and the grand opening of the Company's newest Read more...

Sylentis’ dry eye drug fails to meet primary goals of HELIX trial

Sylentis’ tivanisiran has failed to meet the primary objectives of the Phase III HELIX trial evaluating the efficacy and safety...Read More... The post Sylentis’ dry eye drug fails to meet primary goals of HELIX trial appeared first on Drug Development Technology.

Helix TCS (OTCQB: $HLIX) Expands International Footprint to #Colombia; #CannabisInvestoridea

DENVER - December 19, 2018 (Investorideas.com Newswire) Helix TCS, Inc. (OTCQB: HLIX) (the "Company") has expanded its international footprint to Colombia, with multiple licensed cannabis cultivators and manufacturers already implementing its industry-leading seed-to-sale tracking solution, BioTrackTHC.

$MDGL - opco tgt to $200 from $300 'after the shares were penalized last week by a definition of NASH resolution for MGL-3196 in Phase 2 which is slightly different from that used in ongoing Phase 3 trials'

$MDGL - opco tgt to $200 from $300 'after the shares were penalized last week by a definition of NASH resolution for MGL-3196 in Phase 2 which is slightly different from that used in ongoing Phase 3 trials'

$GBT Very balanced KOL call on sickle cell disease via OpCo. Most interesting comment is that VOC curve separation actually occurs quite early in trials, usually pretty much already done by 12wk.pic.twitter.com/Z4BUBWeDcS

$GBT Very balanced KOL call on sickle cell disease via OpCo. Most interesting comment is that VOC curve separation actually occurs quite early in trials, usually pretty much already done by 12wk. pic.twitter.com/Z4BUBWeDcS

13th Double Helix Medals dinner raises over $4 million

(Cold Spring Harbor Laboratory) Dr. Priscilla Chan, Mark Zuckerberg, and Dr. Larry Norton were honored for their contributions to basic research at the 13th annual Double Helix Medals dinner, hosted by Cold Spring Harbor Laboratory.

TrialScope, Golden Helix, The National Institutes Of Health, And More: News From September 2018

Clinical Informatics News | September was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from TrialScope, Golden Helix, The National Institutes of Health, and more.  

MyVytalics Partners with Helix to Provide Health and Wellness Genomic Insights

MyVytalics, a privately held company, today announced the release of MySleepInsights, a personal genomics app focusing on genes associated with sleep patterns and nutrition. MyVytalics has

Priscilla Chan and Mark Zuckerberg receive Double Helix Medal for their work to accelerate science

(Chan Zuckerberg Initiative) Last night, Chan Zuckerberg Initiative (CZI) founders Priscilla Chan and Mark Zuckerberg received the Double Helix Medal at an event held at the American Museum of Natural History in New York City. Priscilla Chan accepted the award on the couple's behalf.

#Cannabisstocks: Helix TCS (OTCQB: $HLIX) Subsidiary BioTrackTHC To Unveil Next Generation Seed-to-Sale System At MJBizCon

Fort Lauderdale, FL - November 7, 2018 (Investorideas.com Newswire) Helix TCS, Inc. (OTCQB: HLIX) technology subsidiary, BioTrackTHC, will unveil its highly anticipated second-generation seed-to-sale software system at the Marijuana Business Conference (MJBizCon) in Las Vegas, Nevada, November 14-16.

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced a change in the Company’s Board of Directors. The Board has accepted the resignation of Dr. Marek Orlowski as a director of the ...

Helix BioPharma Corp. Extends Period to Exercise Warrants

RICHMOND HILL, Ontario, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to extend the exercise period of a total of 4,546,000 outs...

Helix Biopharma Corp. Closes First Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a first tranche of a private placement financing for gross proceeds of CAD871,200. The Company expects to complete a sec...

Helix BioPharma Corp. Closes Second Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a second tranche of a private placement financing for gross proceeds of CAD342,000. The Company expects to complete a th...

Helix BioPharma Corp. Closes Third Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a third tranche of a private placement financing for gross proceeds of CAD700,800. Helix closed the first and second tra...

Helix BioPharma Corp. Extends Annual Meeting Date

RICHMOND HILL, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has received consent from the Toronto Stock Exchange to extend the date of its annual general meeting of shareholders to a date not later than Apri...

ykkC riboswitches employ an add-on helix to adjust specificity for polyanionic ligands

Helix BioPharma Corp. Announces Fiscal 2018 Year-End Results

RICHMOND HILL, Ontario, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2018. FINANCIAL REVIEW The Company recorded a net loss and total comprehensive loss of $8,625,000 and $10,059,000 (...

Helix BioPharma Corp. Announces Fiscal First Quarter 2019 Results

RICHMOND HILL, Ontario, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the first quarter of fiscal 2019 ending October 31, 2018. FINANCIAL REVIEW The Company recorded a net loss and total comprehensiv...

Helix BioPharma Corp. Closes Final Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a final tranche of a private placement financing for gross proceeds of CAD348,000. The terms of the placement are ...

Helix BioPharma Corp. Provides Clinical Development and Strategic Corporate Update

RICHMOND HILL, Ontario, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer today provides an update on the Company’s strategic plans. Pre-clinical Development The Company extended its collaboration with the Moffitt Cance...

Helix TCS: A Clear Market Leader in Cannabis Ancillary Services-- CFN Media

SEATTLE, WA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing how Helix TCS Inc. (OTCQB: HLIX) aims to close the gap by offering the world’s largest cannabis-focused suite of vertically-integrated services a...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks